Needle-Free Injection Systems Market Company Profiling with Detailed Strategies, Financials, and Recent Developments

The global needle-free injection systems market will experience extensive growth in the coming years due to the rising demand for self-injection devices and emerging biological therapies. The vendors of these systems offer fillable and prefilled needle-free injectors in the market, of which prefilled needle-free injectors constitute the larger share. The increasing demand for low-cost self-injection devices by patients and healthcare providers and rising focus on compliance with needle safety regulations to avoid needlestick injuries are some of the factors that have led to an increase in the use of prefilled needle-free injectors.

Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/needle-free-injection-systems-market

Needle-free injection systems are generally penetrated via intramuscular, subcutaneous, and intradermal routes. These injectors find their application in oncology, insulin delivery, vaccine delivery, pain management, and others. Needle-free injectors finds largest application in vaccine delivery, mainly because of the increasing prevalence of chronic diseases. Insulin delivery application has also witnessed significant growth with the use of needle-free injection systems by the increasing patient base suffering from diabetes.

Request to Get the Sample Pages at: https://www.psmarketresearch.com/market-analysis/needle-free-injection-systems-market/report-sample

Most of the biologics, such as monoclonal antibodies, anticoagulants, and vaccines, are large molecules that need to be administered parenterally to achieve the desired therapeutic effects. The demand for injectable biologic therapies is increasing, since many peptides break down quickly in the stomach, no longer remaining useful for the treatment. Also, various biologic drugs and vaccines are required to be injected directly into the bloodstream. Additionally, the introduction of biosimilars is expected to increase the use of injectables for self-administration; hence, emerging biologic therapies are expected to fuel the growth of the needle-free injection systems market.

In March 2017, PharmaJet announced its partnership with Serum Institute of India to commercialize needle-free delivery of the measles, mumps, and rubella (MMR) vaccine using the Stratis 0.5 mL needle-free injection system.

About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.